单位(元)建信医疗健康行业股票C(008924)利润表 |
| 报告期 |
2025/12/31 |
2025/6/30 |
2024/12/31 |
2024/6/30 |
| 收入 |
219,355,106 |
289,141,980 |
-106,530,198 |
-134,561,543 |
| 利息收入 |
994,083 |
514,892 |
1,329,322 |
750,717 |
| 其中:存款利息收入 |
931,710 |
452,518 |
1,210,573 |
631,968 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
62,373 |
62,373 |
118,748 |
118,748 |
| 投资收益 |
250,278,035 |
121,664,348 |
-71,708,891 |
-71,113,971 |
| 其中:股票投资收益 |
246,183,404 |
119,050,646 |
-84,366,610 |
-81,942,130 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
- |
340,705 |
113,030 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
4,094,631 |
2,613,702 |
12,317,014 |
10,715,130 |
| 公允价值变动收益 |
-35,676,571 |
166,112,222 |
-36,733,108 |
-64,454,669 |
| 汇兑收益 |
- |
- |
- |
- |
| 其他收入 |
3,759,560 |
850,518 |
582,479 |
256,381 |
| 费用 |
17,830,294 |
7,745,145 |
18,136,262 |
9,352,501 |
| 管理人报酬 |
13,186,724 |
5,604,449 |
13,174,870 |
6,824,630 |
| 托管费 |
2,197,787 |
934,075 |
2,195,812 |
1,137,438 |
| 销售服务费 |
2,252,131 |
1,100,308 |
2,558,155 |
1,284,251 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
193,650 |
106,312 |
207,425 |
106,182 |
| 利润总额 |
201,524,813 |
281,396,834 |
-124,666,461 |
-143,914,044 |
| 减:所得税费用 |
- |
- |
- |
- |
| 净利润 |
201,524,813 |
281,396,834 |
-124,666,461 |
-143,914,044 |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。